Related Experiment Video

Updated: Jun 3, 2025

An In Ovo Model for Testing Insulin-mimetic Compounds
06:09

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

10.5K

Exploring the Potential of Epigallocatechin Gallate in Combating Insulin Resistance and Diabetes

Kübra Yurtseven1, Sevinç Yücecan2

  • 1Department of Nutrition and Dietetics, Institute of Health Sciences, Lokman Hekim University, 06510 Çankaya, Ankara, Turkey.

Nutrients
|January 8, 2025
PubMed
Abstract

Insights

Epigallocatechin gallate (EGCG) significantly improves glycemic control and insulin sensitivity in diabetic rats. High doses of EGCG effectively lower blood glucose and enhance beta cell function, suggesting its potential in diabetes management.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Metabolic Disorders

Background:

  • Diabetes mellitus and insulin resistance are significant global health concerns.
  • Effective management strategies are crucial for improving patient outcomes.
  • Natural compounds are being investigated for their therapeutic potential.

Purpose of the Study:

  • To evaluate the effects of epigallocatechin gallate (EGCG) on diabetes and insulin resistance.
  • To assess EGCG's impact on key metabolic parameters in a rodent model.

Main Methods:

  • Utilized streptozotocin (STZ)-induced diabetic male Wistar albino rats.
  • Administered varying doses of EGCG (50 mg/kg, 100 mg/kg, 200 mg/kg).
  • Monitored metabolic parameters related to diabetes and insulin resistance.

Main Results:

  • EGCG demonstrated significant improvements in fasting blood glucose levels, particularly at 200 mg/kg.
  • EGCG reduced insulin resistance and enhanced insulin sensitivity by increasing insulin secretion.
  • High doses of EGCG (100 mg/kg and 200 mg/kg) improved beta cell function.

Conclusions:

  • EGCG shows promise as an effective component in managing diabetes and insulin resistance.
  • Incorporating EGCG into medical nutrition therapy may aid glycemic control and insulin sensitivity.
  • EGCG presents a potential alternative treatment option for diabetes.
Keywords:
beta cell functiondiabetesepigallocatechin gallate (EGCG)glycemic controlinsulin resistanceinsulin sensitivity

More Related Videos

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes08:03

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes

Published on: June 25, 2017

19.9K
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

67.9K

Related Concept Videos

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
165
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
166
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
295
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.1K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
3.1K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.4K